Pertussis antigens and use thereof in vaccination

Details for Australian Patent Application No. 2004277342 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Denoel, Philippe; Castado, Cindy; Poolman, Jan; Godfroid, Fabrice

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004277342

PCT Pub. Number WO2005/032584

Priority 0323113.1 02.10.03 GB; 0323112.3 02.10.03 GB

Filing date 1 October 2004

Wipo publication date 14 April 2005

Acceptance publication date 16 December 2010

International Classifications

A61K 39/10 (2006.01) Medicinal preparations containing antigens or antibodies - Brucella

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032584 Priority application(s): WO2005/032584

16 December 2010 Application Accepted

  Published as AU-B-2004277342

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277346-Bicyclo[3.1.1]heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

2004277341-Fungicidal mixtures